LRP2 and myeloid sarcoma: We did not detect increased megalin expression in any of the cells; we may hypothesize that VitD acts on these cells through some other mechanism, which may explain the decreased megalin mRNA expression in active and chronic MS lesions compared with normal‐appearing white matter (Smolders et al., 2013).